TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
ATR

AptarGroup Inc

Healthcare · Medical Instruments & Supplies

120.40$ -1.2% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

AptarGroup Inc (ATR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 5,133 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ATR
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
2,685 2,607 2,524 2,664 3,409 3,138 3,284 3,222 3,407 3,378 3,416 3,589 3,465 3,562 3,777 3,814 3,862 3,990 3,993 4,110 4,131 4,141 4,407 4,258 4,026 4,203 4,303 4,348 4,298 4,452 4,437 4,453 4,625 4,432 4,527 4,865 5,101 5,253 5,098 5,133
1,302 1,270 1,157 1,244 1,941 1,670 1,793 1,750 1,385 1,331 1,329 1,419 1,325 1,291 1,515 1,344 1,327 1,369 1,407 1,492 1,344 1,358 1,642 1,559 1,400 1,430 1,482 1,516 1,503 1,549 1,560 1,594 1,666 1,478 1,512 1,663 1,784 1,894 1,768 1,835
433 466 285 337 1,019 713 741 718 291 262 217 303 271 242 411 248 227 300 255 291 115 123 356 240 125 142 127 121 152 224 200 221 326 224 126 162 257 402 223 190
433 466 285 337 1,019 713 741 718 291 262 217 303 271 242 411 248 227 300 255 291 115 124 356 240 125 142 127 121 152 224 201 224 328 226 137 170 265 410 229 197
463 433 475 500 510 510 587 583 580 570 600 600 552 558 602 576 593 567 637 657 679 671 694 703 691 677 695 719 717 678 724 738 699 658 743 800 799 804 833 898
322 297 310 320 323 337 348 343 394 381 390 399 383 376 372 382 375 379 394 429 437 441 460 471 463 487 513 516 491 513 497 485 489 462 484 527 547 538 551 580
818 784 799 832 858 868 885 868 981 992 1,007 1,052 1,115 1,088 1,071 1,098 1,140 1,269 1,247 1,224 1,249 1,276 1,341 1,257 1,226 1,402 1,438 1,454 1,442 – – – 1,581 1,511 1,556 1,585 1,707 1,676 – –
425 408 411 430 439 444 451 440 699 712 704 737 722 763 756 862 878 899 884 888 987 974 962 936 910 946 956 957 943 963 953 950 968 936 954 996 1,067 1,078 1,073 1,070
102 94 93 95 97 95 95 89 283 255 247 261 260 291 284 353 348 344 331 322 373 362 348 329 317 316 311 299 287 283 269 258 271 255 250 250 260 255 245 234
1,399 1,433 1,283 1,355 2,087 1,826 1,879 1,875 2,015 1,955 1,948 2,007 1,911 1,990 2,189 2,168 2,102 2,139 2,092 2,123 2,135 2,157 2,409 2,310 2,138 2,135 2,175 2,159 2,085 2,131 2,074 2,043 2,072 1,946 1,976 2,148 2,289 2,540 2,424 2,459
504 543 413 479 705 528 567 581 742 689 624 671 649 683 891 830 787 780 756 783 908 982 861 822 897 917 1,041 1,030 1,232 1,251 1,196 1,168 1,027 1,068 1,208 1,369 1,499 1,166 1,063 1,137
142 175 9.9 7.9 246 67 70 72 217 164 82 123 111 110 286 217 161 118 66 70 201 290 143 70 164 126 231 276 491 458 435 406 253 338 445 552 655 344 222 249
361 116 402 416 446 154 471 503 519 165 525 531 521 193 594 609 622 244 584 605 622 285 624 657 642 320 701 650 655 329 677 680 685 296 664 695 845 341 758 887
777 773 771 771 1,272 1,191 1,200 1,183 1,132 1,119 1,121 1,148 1,075 1,085 1,076 1,083 1,040 1,055 1,038 1,049 916 907 1,295 1,272 1,028 1,053 956 950 680 681 680 682 823 688 561 535 546 1,139 1,143 –
1,286 1,174 1,240 1,309 1,322 1,312 1,404 1,347 1,392 1,423 1,467 1,581 1,554 1,572 1,587 1,646 1,760 1,850 1,900 1,986 1,958 1,969 1,983 1,934 1,875 2,054 2,113 2,174 2,200 2,307 2,349 2,396 2,539 2,472 2,538 2,700 2,797 2,668 2,629 2,628
1,209 1,197 1,215 1,238 1,272 1,301 1,332 1,328 1,346 1,372 1,413 1,465 1,498 1,524 1,555 1,573 1,614 1,644 1,704 1,735 1,757 1,789 1,827 1,866 1,895 1,929 1,959 2,017 2,074 2,110 2,166 2,229 2,300 2,371 2,419 2,501 2,600 2,643 2,684 2,741
65 64 64 65 65 65 64 65 65 65 65 66 67 66 66 66 67 67 68 68 68 67 67 67 67 66 67 67 67 67 67 68 68 68 67 67 67 66 65 65

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?